Results 141 to 150 of about 21,820 (216)

Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infections. [PDF]

Antimicrob Agents Chemother
Karaba SM, Hareza DA, Munita JM, Martinez JRW, Bergman Y, Hawes AM, Bulman ZP, Cosgrove SE, Simner PJ, Tamma PD.   +9 more
europepmc   +1 more source

Combating Carbapenem-Resistant <i>Enterobacterales</i>: Comparative <i>In Vitro</i> Efficacy of Aztreonam-Avibactam and Ceftazidime-Avibactam and Distribution of Carbapenemase Genes. [PDF]

Antibiotics (Basel)
Yaşar Duman M, Kanat M, Tanrıverdi ES, Çilli F, Aydemir Ş.   +4 more
europepmc   +1 more source

Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam. [PDF]

Antimicrob Agents Chemother
Feng C.
europepmc   +1 more source

Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration. [PDF]

Eur J Hosp Pharm
Chen F, Ding H, Liu S, Chen Z, Tang L, Tong T.   +5 more
europepmc   +1 more source

Reply to Feng, "Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam". [PDF]

Antimicrob Agents Chemother
Jousset AB, Girlich D, Oueslati S, Birer A, Delaval A, Guyot C, Rezzoug I, Emeraud C, Naas T, Bonnin RA, Dortet L.   +10 more
europepmc   +1 more source

Ceftazidime-Avibactam/Aztreonam Combination for the Treatment of Carbapenem-resistant Klebsiella pneumoniae-induced Osteomyelitis: A Case Series with Review of Literature. [PDF]

J Orthop Case Rep
Gupta A, Chaudhari H, Kumar R, Mishra AK, Aggarwal N, Saran A.   +5 more
europepmc   +1 more source

Cefiderocol Heteroresistance in NDM-Producing Enterobacterales: A Complex Polymicrobial Infection Successfully Salvaged With Ceftazidime-Avibactam Plus Aztreonam. [PDF]

Am J Case Rep
Nuaimi M, Cirillo J, Usbosy S, Egan D, Kovacich A, Madruga M, Carlan SJ.   +6 more
europepmc   +1 more source

Fitness cost of ceftazidime-avibactam resistance acquisition in carbapenem-resistant hypervirulent Klebsiella pneumoniae. [PDF]

BMC Microbiol
Huang M, Xiao SP, Zeng QH, Guo HM, Liu YT, Wei DD, Kang XH.   +6 more
europepmc   +1 more source

Comparison of agar-based methodologies to broth disc elution for the detection of aztreonam susceptibility in the presence of ceftazidime-avibactam. [PDF]

Microbiol Spectr
Sandstrom TS, Banete A, Kanyua A, Davis KM, Poutanen SM.   +4 more
europepmc   +1 more source

Ceftazidime/Avibactam Monotherapy Versus Other Antibiotics: Where Do We Stand? [PDF]

Pathogens
Vougiouklakis G, Tsioutis C, Vasileiadi N, Alexakis K, Spernovasilis N, Agouridis AP.   +5 more
europepmc   +1 more source